NCT03176199View on ClinicalTrials.gov

A Study to Compare the Titration Efficacy and Safety of Control-released Oxycodone and Immediate-released Oxycodone in Patients With Moderate to Severe Cancer Pain

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 1, 2016

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions

CancerPain

Interventions

DRUG

Oxycodone

Every 12 hours for control-released oxycodone (OxyContin®)

DRUG

Oxycodone

Every 6 hours for immediate-released oxycodone (OxyNorm®)

Trial Locations (4)

500

Changhua Christian Hospital, Chang-hua

10002

National Taiwan University Hospital, Taipei

11217

Taipei Veterans General Hospital, Taipei

40705

Taichung Veterans General Hospital, Taichung

All Listed Sponsors

lead

Taiwan Mundipharma Pharmaceuticals Ltd.

INDUSTRY

NCT03176199 - A Study to Compare the Titration Efficacy and Safety of Control-released Oxycodone and Immediate-released Oxycodone in Patients With Moderate to Severe Cancer Pain | Biotech Hunter | Biotech Hunter